< Back to scientific publications

Magazine 5.44

Pharmacology of new and developing intravenous therapies for the management of seizures and epilepsy.

Authors: Morano A, Iannone L, Palleria C, Fanella M, Giallonardo AT, De Sarro G, Russo E, Di Bonaventura C.

Date: 2018

Scope of interest: Epilepsy




You may also be interested in:

Magazine 7,093

Repaglinide administration improves brachial reactivity in type 2 diabetic patients.

Authors: Manzella D, Grella R, Abbatecola AM, Paolisso G.

Date: 2005

Scope of interest: diabetes


Read details
Magazine 5.5

Tocilizumab for patients with COVID-19pneumonia. The single-arm TOCIVID-19 prospective trial.

Authors: Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy.

Date: 2020

Scope of interest: sars cov 2 therapy


Read details
Magazine 2.12

“Covid Solution”

Authors: Menicagli r

Date: 2020

Scope of interest: infectivology


Read details